About Phase Scientific

PHASE Scientific Americas develops rapid antigen tests for point-of-care and over-the-counter use, specifically targeting the detection of infectious diseases. Their INDICAID health platform offers at-home collection kits and virtual care services, enabling patients to manage their health more effectively.

<problem> Current rapid antigen tests often require a visit to a point-of-care facility or pharmacy. This can be inconvenient, time-consuming, and may delay diagnosis and treatment, particularly for individuals in remote areas or with limited mobility. </problem> <solution> PHASE Scientific Americas offers INDICAID, a suite of rapid antigen tests designed for both point-of-care (POC) and over-the-counter (OTC) use, along with the INDICAID health digital platform. The INDICAID platform includes at-home collection kits and virtual care services, enabling individuals to conveniently manage their health from home. The rapid antigen tests focus on the detection of common infectious diseases, providing accessible and timely diagnostic information. This approach aims to empower individuals to proactively monitor their health and make informed decisions in consultation with healthcare providers. </solution> <features> - INDICAID OTC: Over-the-counter rapid antigen tests for at-home use - INDICAID POC: Point-of-care rapid antigen tests for professional use - INDICAID health: Digital health platform for at-home collection and virtual care - At-home collection kits for diabetes (HbA1c) and heart health (Lipid Panel) - PHASiFY: Proprietary sample preparation technology to advance molecular diagnostic testing - PHASE Lab: CLIA and CAP accredited high complexity lab </features> <target_audience> The primary target audience includes individuals seeking convenient at-home health monitoring solutions, healthcare providers needing rapid point-of-care diagnostics, and organizations looking to provide accessible testing options to their employees or communities. </target_audience>

What does Phase Scientific do?

When was Phase Scientific founded?

Phase Scientific was founded in 2015.

How much funding has Phase Scientific raised?

Phase Scientific has raised 749800.

Founded

2015

Funding

749800

Employees

88 employees

Major Investors

National Science Foundation

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Phase Scientific

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

phasescientific.com 5K+

Crunchbase

Founded 2015

Funding

Estimated Funding

$500K+

Major Investors

National Science Foundation

Team (75+)

No team information available.

Company Description

Problem

Current rapid antigen tests often require a visit to a point-of-care facility or pharmacy. This can be inconvenient, time-consuming, and may delay diagnosis and treatment, particularly for individuals in remote areas or with limited mobility.

Solution

PHASE Scientific Americas offers INDICAID, a suite of rapid antigen tests designed for both point-of-care (POC) and over-the-counter (OTC) use, along with the INDICAID health digital platform. The INDICAID platform includes at-home collection kits and virtual care services, enabling individuals to conveniently manage their health from home. The rapid antigen tests focus on the detection of common infectious diseases, providing accessible and timely diagnostic information. This approach aims to empower individuals to proactively monitor their health and make informed decisions in consultation with healthcare providers.

Features

INDICAID OTC: Over-the-counter rapid antigen tests for at-home use

INDICAID POC: Point-of-care rapid antigen tests for professional use

INDICAID health: Digital health platform for at-home collection and virtual care

At-home collection kits for diabetes (HbA1c) and heart health (Lipid Panel)

PHASiFY: Proprietary sample preparation technology to advance molecular diagnostic testing

PHASE Lab: CLIA and CAP accredited high complexity lab

Target Audience

The primary target audience includes individuals seeking convenient at-home health monitoring solutions, healthcare providers needing rapid point-of-care diagnostics, and organizations looking to provide accessible testing options to their employees or communities.